Breakthroughs are made possible by you! Find a Pfizer clinical trial and learn more about our commitment to clinical trial participants.
Trial Data & Results We publicly share results from our clinical trials, whether the results are neutral, negative, or positive. We also share data gathered in clinical trials we sponsor with trial volunteers, researchers, and others. Data Access Requests Clinical Study Report Synopses ...
Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription. Product Browse All Products Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, ...
As a participant in a clinical trial, you have many rights. Among them are the rights to: leave the study at any time ask questions about any aspect of the study be told what the goal of the study is and what you will be asked to do ...
German biotechnology company BioNTech and U.S. company Pfizer have started clinical trials of an Omicron-based COVID-19 vaccine candidate in healthy adults 18 through 55 years of age, the companies said on Tuesday. The trials would evaluate the safety, tolerability and immunogenicity of the vaccin...
If you are involved in a clinical trial, adverse events should be reported to your coordinating study site. What would you like to report? Adverse event associated with: All Pfizer ProductsREPORT Adverse event reporting from: Company Sponsored ...
across 25,000 people worldwide. This has brought data and decision makers together to drive impact—including the development of models to improve patient identification and diagnosis and to identify ways to have faster, better clinical trials that result in break-through advancements ...
The giant drug company Pfizer is conducting a "virtual" clinical trial that relies solely on electronic rather than face to face encounters between researchers and participants. It announced the trial on 7 June at a conference on clinical trials held on the Bethesda, Maryland, campus of the US...
View studies/programs by Cancer TypePhase FiltersClose Breast Cancer Vepdegestrant (ARV-471)* + Atirmociclib (PF-07220060) PROTAC® Estrogen Receptor Degrader CDK4 Inhibitor Phase 1 Phase 2 KAT6 Inhibitor + Atirmociclib (PF-07220060) ...